Study of Imiquimod Cream Prior to Ablative Therapy in External Ano-Genital Warts

Inclusion Criteria: * Subjects with at least 1 visible genital or perianal wart * Total wart area 1 to 40 square centimeters. Exclusion Criteria: * Pregnant or lactating women * Known other sexually transmitted disease * Evidence of a clinically significant immunodeficiency * Evidence of unstable cardiovascular, pulmonary, hematological, hepatic, renal, endocrine, collagen vascular, neurological or gastrointestinal abnormality or disease. * Treatment within the 4 weeks prior to the Randomization Visit with any of the following systemic or topical treatments: interferons, interferon inducers, immunomodulators, immunosuppressive drugs, antiviral drugs (except for systemic acyclovir, valacyclovir and famciclovir), cytotoxic drugs, investigational drugs, or any drugs known to have major organ toxicity.